Skip to main content
رجوع
BBNX logo

Beta Bionics, Inc.

جودة البيانات: 100%
BBNX
NASDAQ Healthcare Medical - Equipment & Services
KWD 11.31
▲ KWD 0.07 (0.62%)
القيمة السوقية: 501.96M
نطاق اليوم
KWD 11.17 KWD 11.92
نطاق 52 أسبوعًا
KWD 8.89 KWD 32.71
حجم التداول
722,276
متوسط 50 يوم / 200 يوم
KWD 14.10 / KWD 19.89
الإغلاق السابق
KWD 11.24

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E -6.9 0.2
P/B 1.8 3.0
ROE % -40.3 3.6
Net Margin % -73.0 3.8
Rev Growth 5Y % 9.9
D/E 0.0 0.2

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Debt/Equity of 0.04 — conservative balance sheet
Negative free cash flow of 0.0
PEG of 0.21 suggests growth is underpriced
Capital efficient — spends only 0.00% of revenue on capex

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)53.94%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-40.26%
ROIC-17.90%
Net Margin-73.02%
Op. Margin-71.50%

الأمان

Debt / Equity
0.04
Current Ratio8.66
Interest Coverage0.00

التقييم

P/E Ratio
-6.86
Forward P/EN/A
P/B Ratio1.75
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 53.94% Revenue Growth (3Y) 189.10%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 100.25M Net Income (TTM) -73.20M
ROE -40.26% ROA -22.27%
Gross Margin 55.40% Operating Margin -71.50%
Net Margin -73.02% Free Cash Flow (TTM) 0.0
ROIC -17.90% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.04 Current Ratio 8.66
Interest Coverage 0.00
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -6.86 Forward P/E N/A
P/B Ratio 1.75 P/S Ratio 5.01
PEG Ratio 0.21 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 0.00%
Market Cap 501.96M Enterprise Value 482.95M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue 100.25M 65.12M 12.00M 179,000.0
Net Income -73.20M -54.76M -44.10M -64.75M
EPS (Diluted) -1.81 -8.60 -8.31 -12.96
Gross Profit 55.54M 35.89M 6.31M 179,000.0
Operating Income -71.68M -45.25M -35.85M -65.84M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 328.74M 149.65M 110.04M 35.53M
Total Liabilities 41.13M 73.63M 51.43M 22.53M
Shareholders' Equity 287.61M 76.01M 58.61M 13.00M
Total Debt 12.67M 7.26M 4.22M 4.13M
Cash & Equivalents 31.68M 30.43M 26.57M 27.68M
Current Assets 267.90M 132.92M 103.62M 28.47M
Current Liabilities 30.92M 21.15M 10.61M 8.87M